Myocarditis associated with COVID-19 vaccination

A Buoninfante, A Andeweg, G Genov, M Cavaleri - npj Vaccines, 2024 - nature.com
Following the start of the COVID-19 vaccination campaign, the adverse events of myocarditis
and pericarditis were linked mainly to mRNA COVID-19 vaccines by the regulatory …

Innate and adaptive immunity during SARS-CoV-2 infection: biomolecular cellular markers and mechanisms

B Brown, V Ojha, I Fricke, SA Al-Sheboul, C Imarogbe… - Vaccines, 2023 - mdpi.com
The coronavirus 2019 (COVID-19) pandemic was caused by a positive sense single-
stranded RNA (ssRNA) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

IL-1RA antibodies in myocarditis after SARS-CoV-2 vaccination

L Thurner, C Kessel, N Fadle, E Regitz… - … England Journal of …, 2022 - Mass Medical Soc
IL-1RA Antibodies in Myocarditis after SARS-CoV-2 Vaccination | New England Journal of
Medicine Skip to main content The New England Journal of Medicine homepage Advanced …

Multisystem inflammatory syndrome in children and long COVID: the SARS-CoV-2 viral superantigen hypothesis

M Noval Rivas, RA Porritt, MH Cheng, I Bahar… - Frontiers in …, 2022 - frontiersin.org
Multisystem inflammatory syndrome in children (MIS-C) is a febrile pediatric inflammatory
disease that may develop weeks after initial SARS-CoV-2 infection or exposure. MIS-C …

Targeted removal of macrophage-secreted interleukin-1 receptor antagonist protects against lethal Candida albicans sepsis

HTT Gander-Bui, J Schläfli, J Baumgartner, S Walthert… - Immunity, 2023 - cell.com
Invasive fungal infections are associated with high mortality rates, and the lack of efficient
treatment options emphasizes an urgency to identify underlying disease mechanisms. We …

Molecular mimicry in multisystem inflammatory syndrome in children

A Bodansky, RC Mettelman, JJ Sabatino Jr… - Nature, 2024 - nature.com
Multisystem inflammatory syndrome in children (MIS-C) is a severe, post-infectious sequela
of SARS-CoV-2 infection,, yet the pathophysiological mechanism connecting the infection to …

A localizing nanocarrier formulation enables multi-target immune responses to multivalent replicating RNA with limited systemic inflammation

T Kimura, JM Leal, A Simpson, NL Warner, BJ Berube… - Molecular Therapy, 2023 - cell.com
RNA vaccines possess significant clinical promise in counteracting human diseases caused
by infectious or cancerous threats. Self-amplifying replicon RNA (repRNA) has been thought …

Recent advances and evolving concepts in Still's disease

P Ruscitti, L Cantarini, PA Nigrovic… - Nature Reviews …, 2024 - nature.com
Still's disease is a rare inflammatory syndrome that encompasses systemic juvenile
idiopathic arthritis and adult-onset Still's disease, both of which can exhibit life-threatening …

Immunology of multisystem inflammatory syndrome after COVID-19 in children: a review of the current evidence

F Filippatos, EB Tatsi, A Michos - International Journal of Molecular …, 2023 - mdpi.com
Immune responses following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) in children are still under investigation. Even though coronavirus disease 2019 (COVID …

Transient anti-cytokine autoantibodies superimpose the hyperinflammatory response in Kawasaki disease and multisystem inflammatory syndrome in children: A …

SA Netea, G Biesbroek, D van Stijn, H Ijspeert… - …, 2023 - thelancet.com
Summary Background Children with SARS-CoV-2 related Multisystem Inflammatory
Syndrome in Children (MIS-C) often present with clinical features that resemble Kawasaki …